VC Phf6 + JAK3M511I T-ALL mice were treated with placebo, single tofacitinib, single idasanutlin, or combined tofacitinib + idasanutlin (To + Id) (Fig. 7A). This evidence concerns the gene PHF6 and acute lymphoblastic leukemia.